Hexagon Nutrition IPO: Dates, Price Band, GMP 2026

What has been announced

Hexagon Nutrition’s initial public offering (IPO) is scheduled to open for subscription on 5 June 2026 and close on 9 June 2026. The company has fixed a price band of ₹42 to ₹45 per share for the book-built issue. Multiple reports peg the IPO size at around ₹139 crore, with a more specific figure of ₹138.87 crore also cited.

The offering is positioned as a mainboard IPO and is slated to list on both BSE and NSE. Key downstream milestones such as allotment, refunds, and demat credit dates have also been indicated, giving investors a clear timetable for the issue process.

Subscription window and key timeline

The bidding window runs for five days, from Friday, 5 June to Tuesday, 9 June. The basis of allotment is expected to be finalised on 10 June 2026, followed by the operational steps of refunds and credit of shares.

The tentative listing date is 12 June 2026 on NSE and BSE. This schedule is important for applicants tracking fund blockage duration and the expected time to listing.

Price band, lot size, and minimum investment

Hexagon Nutrition has set its IPO price band at ₹42-₹45 per equity share. The face value is stated as ₹1 per share. The market lot is 333 shares, and investors can apply starting from one lot.

At the upper end of the price band, the minimum application amount works out to ₹14,985 for 333 shares. A maximum retail application amount is also cited as ₹1,94,805 for 13 lots.

Issue size and share count mentioned

Across the sources provided, the total issue size is stated as ₹138.87 crore (also referred to as about ₹139 crore). The issue is described as comprising 30,859,704 equity shares (also written as 3,08,59,704 shares) of face value ₹1 each.

One set of details states that pre-issue shareholding stands at 12,29,18,109 shares and will remain the same post-issue, aligning with an offer structure that does not add new shares.

Offer structure: OFS-only and what it means

The IPO is described as entirely an Offer for Sale (OFS) of up to 30.86 million equity shares, with no fresh issue component. As a result, the issue objective section explicitly notes that Hexagon Nutrition will not receive any proceeds from the IPO.

The selling shareholders named include Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar, who are stated to be diluting their holdings through the OFS.

Some text also states that “all proceeds from the offer will go to the company,” but the same material elsewhere repeatedly characterises the transaction as a 100% OFS and also says the company will not receive proceeds. Readers should rely on the issue objective and offer structure description provided alongside the OFS-only detail.

Investor category allocation

The net issue allocation is stated as:

• 50% reserved for Qualified Institutional Buyers (QIBs)
• 35% for Retail investors
• 15% for Non-Institutional Investors (NIIs) (also described as “at least 15%”)

These buckets shape subscription dynamics and are a standard reference point for tracking oversubscription by category during the bidding window.

Grey market premium (GMP): mixed signals reported

Grey market commentary in the provided text is inconsistent across trackers and dates. One update states the IPO had no grey market activity and cites a GMP of ₹0, indicating an expected listing around the issue price. Another update also says that on 30 May 2026, the GMP stands at ₹0.

But other portions of the same compiled material report GMP at ₹10, including a figure described as ₹10 (22.22%). Taken together, the data suggests GMP readings may vary by source and timestamp, and the reported GMP should be treated as a snapshot rather than a fixed indicator.

Company snapshot and sector positioning

Hexagon Nutrition Ltd. is described as being established in 1993 and operating in the Food Processing and Packaging segment. It is also described as operating in the nutrition and wellness space, with product categories including clinical nutrition, therapeutic foods, micronutrient premixes, whey protein, Omega-3 supplements, and health supplements.

One analysis note in the provided text mentions profit growth, stating profits increased from ₹5.8 crore in FY23 to ₹24.38 crore in FY25. No additional financial line items are provided in the source material.

Key IPO details at a glance

Timeline for allotment, refunds, and demat credit

Market impact: what investors are watching

The two headline variables highlighted are the OFS-only structure and the grey market indicators. Because the IPO is described as a 100% OFS with no fresh issue, the company is stated to not receive funds, which matters for investors assessing whether the issue strengthens the balance sheet or funds growth initiatives.

Meanwhile, the GMP updates range from ₹0 (including a dated reference to 30 May 2026) to ₹10 in other snippets. Since GMP is informal and not an exchange-traded indicator, market participants typically track it as a sentiment gauge, but the mixed readings here underline the importance of checking the latest timestamped updates.

Why the details matter

For applicants, the practical decision points in the provided material are clear: the ₹42-₹45 price band, the 333-share lot size, and the ₹14,985 minimum cheque size at the top of the band. The timetable from June 5 to June 12 also sets expectations on capital lock-in until allotment and listing.

For longer-term investors, the text flags one core structural point: a sell-down by existing shareholders rather than a capital raise for the company. The provided profit figures for FY23 and FY25 add context, but no additional disclosures are included here to expand on valuation or use-of-funds, since the issue is stated to be OFS-only.

Conclusion

Hexagon Nutrition’s IPO opens 5 June 2026 with a ₹42-₹45 price band, a ₹138.87 crore issue size (about ₹139 crore), and a 333-share minimum lot, with listing targeted for 12 June on BSE and NSE. Reported GMP signals vary between ₹0 and ₹10 across sources and dates. The next confirmed milestone after bidding is the basis of allotment expected on 10 June 2026.